WELLS FARGO & COMPANY/MN - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 44 filers reported holding ONCOCYTE CORP in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q2 2023$259
-8.8%
1,125
+40.6%
0.00%
Q1 2023$284
-56.6%
800
-60.8%
0.00%
Q4 2022$655
-34.5%
2,039
+164.5%
0.00%
Q3 2022$1,0000.0%771
-4.6%
0.00%
Q2 2022$1,000
-97.7%
808
-97.2%
0.00%
Q1 2022$43,000
-59.4%
28,923
-40.7%
0.00%
Q4 2021$106,000
-60.4%
48,808
-35.0%
0.00%
Q3 2021$268,000
+1575.0%
75,107
+2540.0%
0.00%
Q2 2021$16,000
-87.5%
2,845
-88.4%
0.00%
Q1 2021$128,000
-59.1%
24,573
-81.2%
0.00%
Q4 2020$313,000
+458.9%
130,951
+221.4%
0.00%
Q3 2020$56,000
-41.7%
40,738
-18.6%
0.00%
Q2 2020$96,000
-61.1%
50,018
-50.2%
0.00%
Q1 2020$247,000
+9.8%
100,513
+0.4%
0.00%
Q4 2019$225,000
+19.0%
100,157
+11.7%
0.00%
Q3 2019$189,000
+98.9%
89,694
+135.8%
0.00%
Q2 2019$95,00038,035
+77522.4%
0.00%
Q1 2019$0490.0%0.00%
Q4 2018$049
-50.5%
0.00%
Q3 2018$0990.0%0.00%
Q2 2018$0
-100.0%
99
-86.0%
0.00%
Q1 2018$1,000
-66.7%
706
+1.6%
0.00%
Q4 2017$3,000
+50.0%
695
+89.4%
0.00%
Q3 2017$2,000367
+270.7%
0.00%
Q2 2017$0990.0%0.00%
Q1 2017$099
+98.0%
0.00%
Q4 2016$0500.0%0.00%
Q3 2016$0500.0%0.00%
Q2 2016$0
-100.0%
50
-96.6%
0.00%
Q1 2016$7,0001,4780.00%
Other shareholders
ONCOCYTE CORP shareholders Q2 2017
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 23,353,697$17,048,0001.30%
AWM Investment Company, Inc. 7,746,557$5,655,0000.86%
PURA VIDA INVESTMENTS, LLC 18,056,274$13,181,0000.76%
Defender Capital, LLC. 2,551,980$1,883,0000.74%
Penbrook Management LLC 563,350$411,0000.35%
ACT CAPITAL MANAGEMENT, LLC 330,000$241,0000.33%
CALIBER WEALTH MANAGEMENT, LLC 75,120$55,0000.04%
Fort Sheridan Advisors LLC 135,000$99,0000.03%
Orbimed Advisors 1,882,768$1,374,0000.03%
WEALTH EFFECTS LLC 51,000$37,0000.02%
View complete list of ONCOCYTE CORP shareholders